Tiny Gold Firm Stuns Wall Street with High-Grade Gold Discovery
Surrounded by the operations of NYSE-listed gold giants, see how this tiny exploration firm planted its flag in the sweet spot of an emerging gold area-play in Canada’s richest mineral belt. Trading below US$0.25 per share and hitting high-grade gold with each turn of the drill, what’s not to like?
Get the details here...
pixel

DRNA Insider Trading (Dicerna Pharmaceuticals)

Insider Ownership Percentage: 11.30%
Insider Buying (Last 12 Months): $180,600.00
Insider Selling (Last 12 Months): $29,696,145.25

Dicerna Pharmaceuticals Insider Trading History Chart

Dicerna Pharmaceuticals Share Price & Price History

$26.09
▼ -0.33 (-1.25%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Finance PhD: Move Your Money Before April 30th
The clock just starting ticking on the biggest financial event in 20 years. The next few weeks could decide your wealth in 2021.
See what you should do now

Dicerna Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2021Bob D BrownEVPSell8,312$25.87$215,031.4429,829  
4/1/2021Regina M PagliaInsiderSell4,431$25.86$114,585.664,431  
2/5/2021James B WeissmanCOOSell7,156$26.99$193,140.4420,904  
2/3/2021Bob D BrownEVPSell8,312$25.00$207,800.00
1/25/2021Bob D BrownEVPSell21,630$25.00$540,750.0043,147  
1/25/2021Regina M PagliaInsiderSell6,326$25.00$158,150.006,326  
1/12/2021Bob D BrownInsiderSell5,808$24.07$139,798.5626,517  
1/11/2021James B WeissmanCOOSell3,800$23.99$91,162.0040,510  
12/10/2020Adam KoppelDirectorSell1,000,000$23.40$23,400,000.00  
12/1/2020Bob D BrownInsiderSell8,185$25.19$206,180.1534,702  
12/1/2020James B WeissmanCOOSell4,360$25.21$109,915.6036,220  
11/4/2020Regina M PagliaInsiderSell30,000$22.75$682,500.0030,000  
11/2/2020Bob D BrownInsiderSell8,185$21.03$172,130.5534,702  
11/2/2020James B WeissmanCOOSell4,360$20.95$91,342.0036,220  
10/16/2020Bob D BrownInsiderSell16,370$21.00$343,770.0042,887  
10/15/2020James B WeissmanCOOSell8,720$20.20$176,144.0030,580  
9/1/2020Douglas FambroughCEOBuy10,000$18.06$180,600.0022,300  
8/3/2020Bob D BrownInsiderSell8,185$22.48$183,998.8013,185  
8/3/2020James B WeissmanCOOSell4,360$22.47$97,969.2025,961  
7/1/2020Bob D BrownInsiderSell8,185$26.50$216,902.5013,185  
7/1/2020James B WeissmanCOOSell4,360$26.53$115,670.8026,220  
6/19/2020Bob D BrownInsiderSell9,670$25.00$241,750.0014,670  
6/1/2020Bob D BrownInsiderSell8,185$21.01$171,966.8513,185  
6/1/2020James B WeissmanCOOSell4,360$21.06$91,821.6026,220  
5/11/2020Bob D BrownInsiderSell13,281$24.00$318,744.0018,281  
5/5/2020Bob D BrownInsiderSell8,185$21.00$171,885.0013,185  
5/4/2020James B WeissmanCOOSell4,360$20.20$88,072.0026,220  
4/20/2020Bob D BrownInsiderSell13,281$23.00$305,463.0013,185  
4/20/2020John B. GreenCFOSell25,624$22.95$588,070.80  
4/17/2020Bob D BrownInsiderSell8,185$21.18$173,358.3013,185  
4/13/2020James B WeissmanCOOSell4,360$20.20$88,072.0026,220  
4/7/2020John B. GreenCFOSell20,469$19.95$408,356.55  
3/2/2020Bob D BrownInsiderSell8,185$21.00$171,885.0013,185  
3/2/2020James B WeissmanCOOSell4,360$20.61$89,859.6026,220  
2/10/2020Bob D BrownInsiderSell8,185$21.00$171,885.0010,650  
2/3/2020James B WeissmanCOOSell4,360$20.20$88,072.0026,220  
1/17/2020John B. GreenCFOSell47,969$21.27$1,020,300.63  
1/2/2020James B WeissmanCOOSell4,360$21.88$95,396.8023,360  
12/31/2019Bob D BrownInsiderSell11,941$22.00$262,702.0017,855  
12/18/2019Douglas FambroughCEOSell80,000$25.87$2,069,600.00  
12/4/2019Adam KoppelDirectorSell1,500,000$24.68$37,020,000.00  
12/2/2019James B WeissmanCOOSell20,000$26.00$520,000.0034,704  
12/2/2019Peter KolchinskyDirectorSell137,176$24.98$3,426,656.48  
11/29/2019Peter KolchinskyDirectorSell138,000$24.22$3,342,360.00  
11/27/2019Peter KolchinskyDirectorSell368,700$24.04$8,863,548.00  
11/25/2019John B. GreenCFOSell12,500$24.95$311,875.00  
11/25/2019Peter KolchinskyDirectorSell361,200$24.06$8,690,472.00  
11/21/2019Peter KolchinskyDirectorSell351,505$22.98$8,077,584.90  
11/19/2019Bain Capital Life Sciences InvMajor ShareholderSell1,750,000$22.03$38,552,500.00  
11/19/2019James B WeissmanCOOSell20,000$24.00$480,000.0034,704  
11/19/2019Peter KolchinskyDirectorSell397,183$23.92$9,500,617.36  
11/18/2019John B. GreenCFOSell12,500$21.05$263,125.00  
11/14/2019James B WeissmanCOOSell20,000$20.00$400,000.0034,704  
11/14/2019John B. GreenCFOSell3,562$20.00$71,240.00  
10/31/2019James B WeissmanCOOSell15,000$18.00$270,000.0029,704  
10/31/2019John B. GreenCFOSell12,500$18.00$225,000.00  
8/23/2019James B WeissmanInsiderSell14,680$13.07$191,867.609,800  
5/29/2019Bain Capital Life Sciences InvDirectorSell1,600,000$12.50$20,000,000.00  
4/2/2019James B WeissmanInsiderSell15,000$15.00$225,000.0039,480  
11/6/2018Brian K HalakDirectorSell335,000$13.33$4,465,550.00  
11/1/2018Brian K HalakDirectorSell564,300$13.66$7,708,338.00  
10/30/2018Brian K HalakDirectorSell245,096$13.92$3,411,736.32  
9/5/2018James B WeissmanInsiderSell2,301$17.50$40,267.5026,781  
8/15/2018Dennis LangerDirectorSell14,531$16.00$232,496.0029,064  
5/9/2018James B WeissmanInsiderSell10,000$15.00$150,000.0019,800  
4/20/2018James B WeissmanInsiderSell8,965$13.00$116,545.009,800  
See Full Table

SEC Filings (Institutional Ownership Changes) for Dicerna Pharmaceuticals (NASDAQ:DRNA)

80.64% of Dicerna Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Dicerna Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
4/6/2021TrimTabs Asset Management LLC18,314$0.44M0.2%N/A0.024%
4/5/2021Pacer Advisors Inc.2,800$72K0.0%-12.1%0.004%
3/12/2021DekaBank Deutsche Girozentrale78,200$1.73M0.0%-4.8%0.102%
3/4/2021Hudson Bay Capital Management LP170,000$3.75M0.0%-48.5%0.223%
3/1/2021UBS Asset Management Americas Inc.335,982$7.40M0.0%-5.1%0.448%
2/24/2021Virtu Financial LLC30,228$0.67M0.1%N/A0.040%
2/23/2021Principal Financial Group Inc.32,144$0.71M0.0%+124.6%0.043%
2/19/2021JPMorgan Chase & Co.799,309$17.61M0.0%+34.8%1.065%
2/17/2021Jane Street Group LLC29,018$0.64M0.0%-49.2%0.039%
2/16/2021Silverarc Capital Management LLC227,388$5.01M2.9%N/A0.303%
2/16/2021Squarepoint Ops LLC19,215$0.42M0.0%-72.6%0.026%
2/16/2021Glenmede Trust Co. NA13,290$0.29M0.0%+10.8%0.018%
2/16/2021Baker BROS. Advisors LP102,121$2.25M0.0%-9.7%0.136%
2/16/2021Nuveen Asset Management LLC411,792$9.07M0.0%+1.7%0.549%
2/16/2021Price T Rowe Associates Inc. MD2,072,217$45.65M0.0%-1.0%2.761%
2/16/2021ETF Managers Group LLC36,501$0.82M0.0%-12.5%0.049%
2/16/2021Schroder Investment Management Group239,393$5.27M0.0%+1.9%0.319%
2/16/2021Engineers Gate Manager LP30,660$0.68M0.0%N/A0.041%
2/16/2021ExodusPoint Capital Management LP97,257$2.14M0.0%-6.8%0.130%
2/16/2021Charles Schwab Investment Management Inc.519,507$11.45M0.0%+2.0%0.692%
2/13/2021American International Group Inc.54,303$1.20M0.0%+39.8%0.072%
2/12/2021Caas Capital Management LP489,765$10.79M0.1%N/A0.653%
2/12/2021Bamco Inc. NY37,962$0.84M0.0%+232.9%0.051%
2/12/2021Penserra Capital Management LLC1,720$37K0.0%+169.6%0.002%
2/12/2021The Manufacturers Life Insurance Company39,933$0.88M0.0%+4.6%0.053%
2/12/2021Credit Suisse AG108,428$2.39M0.0%+3.8%0.144%
2/12/2021Virtus ETF Advisers LLC11,939$0.26M0.1%-22.3%0.016%
2/11/2021Northern Trust Corp833,896$18.37M0.0%-1.9%1.111%
2/11/2021First Mercantile Trust Co.4,723$0.10M0.0%-16.9%0.006%
2/11/2021Barclays PLC26,255$0.58M0.0%-22.6%0.035%
2/11/2021Citigroup Inc.24,712$0.54M0.0%+184.2%0.033%
2/10/2021Rhumbline Advisers88,831$1.96M0.0%-1.2%0.118%
2/10/2021Renaissance Technologies LLC686,878$15.13M0.0%-40.2%0.915%
2/10/2021Panagora Asset Management Inc.300,504$6.62M0.0%+314.7%0.400%
2/9/2021Wells Fargo & Company MN151,792$3.35M0.0%-3.6%0.202%
2/9/2021Hancock Whitney Corp38,095$0.84M0.0%-21.6%0.051%
2/9/2021Duality Advisers LP23,995$0.53M0.0%N/A0.032%
2/9/2021ClariVest Asset Management LLC56,129$1.24M0.0%-38.7%0.075%
2/9/2021Bank of New York Mellon Corp278,598$6.14M0.0%+0.7%0.371%
2/9/2021Oregon Public Employees Retirement Fund12,857$0.28M0.0%-16.0%0.017%
2/9/2021Mitsubishi UFJ Kokusai Asset Management Co. Ltd.10,648$0.24M0.0%+27.1%0.014%
2/9/2021ProShare Advisors LLC26,194$0.58M0.0%+31.2%0.035%
2/8/2021Railway Pension Investments Ltd36,374$0.80M0.0%N/A0.048%
2/8/2021Russell Investments Group Ltd.65,592$1.44M0.0%-43.7%0.087%
2/5/2021BlackRock Inc.6,034,729$132.94M0.0%+4.1%8.041%
2/5/2021Aperio Group LLC13,025$0.29M0.0%N/A0.017%
2/5/2021Swiss National Bank143,100$3.15M0.0%+0.5%0.191%
2/5/2021SG Americas Securities LLC31,994$0.71M0.0%-6.4%0.043%
2/5/2021US Bancorp DE19,448$0.43M0.0%+13.1%0.026%
2/4/2021Los Angeles Capital Management LLC48,554$1.07M0.0%-5.1%0.064%
2/4/2021GSA Capital Partners LLP19,688$0.43M0.1%-19.3%0.026%
2/4/2021State of Wisconsin Investment Board92,700$2.04M0.0%-11.0%0.124%
2/3/2021State of New Jersey Common Pension Fund D106,671$2.35M0.0%-14.6%0.142%
2/2/2021California Public Employees Retirement System140,471$3.10M0.0%-4.9%0.187%
2/2/2021First Trust Advisors LP31,226$0.69M0.0%-61.3%0.042%
2/1/2021Victory Capital Management Inc.54,666$1.20M0.0%-3.4%0.073%
2/1/2021Assenagon Asset Management S.A.133,372$2.94M0.0%-9.5%0.178%
1/29/2021Emerald Mutual Fund Advisers Trust461,958$10.18M0.4%+31.3%0.616%
1/29/2021Emerald Advisers LLC584,342$12.87M0.4%+12.9%0.779%
1/28/2021Arizona State Retirement System18,354$0.40M0.0%-3.2%0.024%
1/28/2021Zurcher Kantonalbank Zurich Cantonalbank8,744$0.19M0.0%+24.1%0.012%
1/25/2021Strs Ohio41,300$0.91M0.0%-4.0%0.055%
1/22/2021Candriam Luxembourg S.C.A.1,408,993$31.04M0.2%+16.5%1.878%
1/19/2021Ritholtz Wealth Management10,000$0.22M0.0%-22.2%0.013%
1/19/2021DNB Asset Management AS15,614$0.34M0.0%N/A0.021%
1/13/2021Hamilton Lane Advisors LLC29,905$0.66M0.2%+120.3%0.040%
1/8/2021Diversified Trust Co9,343$0.21M0.0%N/A0.012%
12/14/2020Strs Ohio43,000$0.77M0.0%+22.2%0.057%
11/19/2020Schonfeld Strategic Advisors LLC59,744$1.08M0.0%+155.0%0.080%
11/17/2020California State Teachers Retirement System98,947$1.78M0.0%+1.0%0.132%
11/17/2020Schonfeld Strategic Advisors LLC59,744$1.08M0.0%+155.0%0.080%
11/16/2020AQR Capital Management LLC110,366$1.99M0.0%-15.7%0.147%
11/16/2020Camber Capital Management LP525,000$9.45M0.5%N/A0.700%
11/16/2020Squarepoint Ops LLC70,016$1.26M0.0%+342.0%0.093%
11/16/2020ExodusPoint Capital Management LP104,335$1.88M0.0%N/A0.139%
11/16/2020Advisors Asset Management Inc.8,759$0.16M0.0%+86.3%0.012%
11/13/2020Morgan Stanley11,365$0.21M0.0%-65.3%0.015%
11/13/2020ProShare Advisors LLC19,962$0.36M0.0%-3.3%0.027%
11/13/2020Charles Schwab Investment Management Inc.509,238$9.16M0.0%+7.3%0.679%
11/13/2020UBS Asset Management Americas Inc.353,958$6.37M0.0%+0.8%0.472%
11/13/2020Virtus ETF Advisers LLC15,364$0.28M0.1%-12.0%0.020%
11/13/2020Great West Life Assurance Co. Can1,792$27K0.0%-53.8%0.002%
11/13/2020AXA S.A.274,659$4.94M0.0%+20.8%0.366%
11/12/2020Connor Clark & Lunn Investment Management Ltd.297,971$5.36M0.0%+9.4%0.397%
11/12/2020JPMorgan Chase & Co.593,138$10.91M0.0%+15.9%0.790%
11/12/2020AlphaCrest Capital Management LLC24,100$0.43M0.0%+78.5%0.032%
11/12/2020Arrowstreet Capital Limited Partnership144,578$2.60M0.0%+615.7%0.193%
11/12/2020O Shaughnessy Asset Management LLC15,223$0.28M0.0%-9.6%0.020%
11/12/2020Federated Hermes Inc.108,260$1.95M0.0%-8.6%0.144%
11/12/2020Sphera Funds Management LTD.199,980$3.60M0.4%N/A0.266%
11/10/2020US Bancorp DE17,194$0.31M0.0%+326.1%0.023%
11/10/2020AJO LP28,307$0.51M0.0%-69.7%0.038%
11/10/2020State Street Corp3,139,373$56.48M0.0%+9.5%4.216%
11/9/2020SG Americas Securities LLC34,184$0.62M0.0%+37.1%0.046%
11/9/2020The Manufacturers Life Insurance Company38,179$0.69M0.0%-1.7%0.051%
11/9/2020ClariVest Asset Management LLC91,626$1.65M0.1%-3.7%0.123%
11/9/2020Victory Capital Management Inc.56,584$1.02M0.0%+12.6%0.076%
11/9/2020Swiss National Bank142,400$2.56M0.0%+1.8%0.191%
11/9/2020State Board of Administration of Florida Retirement System22,114$0.40M0.0%+2.7%0.030%
11/6/2020BlackRock Inc.5,798,854$104.32M0.0%-2.3%7.788%
Data available starting January 2016

See Full Table
Dicerna Pharmaceuticals logo
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare, cardiometabolic, viral, and chronic liver diseases; complement-mediated diseases; and neurodegenerative diseases and pain. Its principal development programs include nedosiran for the treatment of primary hyperoxaluria; RG6346 for the treatment of chronic hepatitis B virus infection; belcesiran for the treatment of deficiency-associated liver disease; and DCR-AUD for the treatment of alcohol use disorder. Dicerna Pharmaceuticals, Inc. has strategic collaborations with Novo Nordisk A/S, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., Eli Lilly and Company, Alnylam Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., and Boehringer Ingelheim International GmbH. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Read More

Today's Range

Now: $26.09
$25.62
$26.63

50 Day Range

MA: $26.58
$22.91
$29.51

52 Week Range

Now: $26.09
$16.50
$29.90

Volume

536,996 shs

Average Volume

826,528 shs

Market Capitalization

$1.99 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.33

Who are the company insiders with the largest holdings of Dicerna Pharmaceuticals?

Dicerna Pharmaceuticals' top insider investors include:
  1. Bob D Brown (EVP)
  2. Bob D Brown (Insider)
  3. James B Weissman (COO)
  4. Regina M Paglia (Insider)
  5. Douglas Fambrough (CEO)
  6. James B Weissman (Insider)
  7. Adam Koppel (Director)
  8. Bain Capital Life Sciences Inv (Director)
  9. Bain Capital Life Sciences Inv (Major Shareholder)
  10. John B Green (CFO)
  11. Peter Kolchinsky (Director)

Who are the major institutional investors of Dicerna Pharmaceuticals?

Dicerna Pharmaceuticals' top institutional shareholders include:
  1. TrimTabs Asset Management LLC — 0.02%
  2. Pacer Advisors Inc. — 0.00%

Which major investors are selling Dicerna Pharmaceuticals stock?

During the last quarter, DRNA stock was sold by these institutional investors:
  1. Pacer Advisors Inc.
Within the last year, company insiders that have sold Dicerna Pharmaceuticals company stock include:
  1. Bob D Brown (EVP)
  2. Bob D Brown (Insider)
  3. James B Weissman (COO)
  4. Regina M Paglia (Insider)
  5. Douglas Fambrough (CEO)
  6. James B Weissman (Insider)

Which major investors are buying Dicerna Pharmaceuticals stock?

During the previous quarter, DRNA stock was purchased by institutional investors including:
  1. TrimTabs Asset Management LLC
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel